Form 4: NHC Director Sells Stock, Updates Option Grants
Insider Transaction Report
National Healthcare Corp. Director Emil E. Hassan reported the sale of 5,500 shares of common stock and updated details on his derivative holdings.
Summary
- Director Emil E. Hassan sold 5,500 shares of National Healthcare Corp. common stock.
- The transaction occurred on November 12, 2025, at a price of $133 per share.
- Following the sale, Hassan beneficially owns 73,095 shares of common stock directly.
- The filing corrected an error regarding the 2025 grant of options to purchase common stock, which was previously mislabeled as a 2024 grant.
- Hassan holds 7,500 options from each of the 2021, 2022, 2023, 2024, and 2025 grants, totaling 37,500 derivative securities.
Sentiment
Score: 4
Explanation: The sale of shares by a director, while not inherently catastrophic, can be perceived negatively by the market as it might signal a lack of confidence or a belief that the stock is fully valued. However, the amount sold is not a majority of their holdings.
Negatives
- Director Emil E. Hassan sold 5,500 shares of common stock, which can be perceived as a negative signal by the market.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: May interpret the director's sale as a negative signal, potentially leading to downward pressure on the stock price.
Key Dates
| Date | Description |
|---|---|
| 05/06/2022 | Date exercisable for 2021 Option Grant |
| 05/05/2023 | Date exercisable for 2022 Option Grant |
| 05/04/2024 | Date exercisable for 2023 Option Grant |
| 05/08/2025 | Original filing date for erroneous 2024 Grant (corrected to 2025 Grant) |
| 05/09/2025 | Date exercisable for 2024 Option Grant |
| 11/12/2025 | Transaction Date for common stock sale and filing date |
| 05/05/2026 | Expiration Date for 2021 Option Grant |
| 05/08/2026 | Date exercisable for 2025 Option Grant |
| 05/04/2027 | Expiration Date for 2022 Option Grant |
| 05/03/2028 | Expiration Date for 2023 Option Grant |
| 05/08/2029 | Expiration Date for 2024 Option Grant |
| 05/07/2030 | Expiration Date for 2025 Option Grant |
Recommendation
holdWhile the director's sale of 5,500 shares at $133 could be seen as a negative signal, it represents a relatively small portion of their total beneficial ownership (73,095 shares plus 37,500 options). Without further context on the director's personal financial situation or other company news, it is difficult to determine if this is a significant bearish indicator or simply personal portfolio management. Therefore, a 'Hold' recommendation is appropriate, advising investors to monitor future insider activity and company performance before making a definitive buy or sell decision.
Keywords
SEC Form 4, insider trading, stock sale, director, NHC, National Healthcare Corp, beneficial ownership, stock options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.